MEN 2 syndrome masquerading as MEN 1
Authors:
- Rajeev ParamesawaranRPRajeev Paramesawaran
- Ben PhillipsBPBen Phillips
- Greg SadlerGSGreg Sadler
Open Access
- 1 September 2012
- journal article
- case report
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 94 (6) , 206-207
Abstract
Patients with multiple endocrine neoplasia (MEN) type 2A develop medullary thyroid cancer, which is associated with poor prognosis in its metastatic stage. Hyperparathyroidism is a common finding in both MEN 1 and 2. We report a 68-year-old patient diagnosed clinically with MEN 1 based on the presence of hyperparathyroidism and pituitary Cushing's disease with no supporting genetic evidence. The hyperparathyroidism was later found to be part of MEN 2A with underlying metastatic medullary thyroid cancer. We highlight the importance of genetic confirmation before a diagnosis of MEN 1 is made as other more serious pathologies might be overlooked.Keywords
This publication has 4 references indexed in Scilit:
- Pheochromocytoma in MEN 2A Syndrome. Study of 54 PatientsWorld Journal of Surgery, 2008
- Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1Clinical Endocrinology, 2000
- Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of theRETProto-Oncogene1The Journal of Clinical Endocrinology & Metabolism, 1998
- An Overview: Clinical Management for MEN I PatientsThe Journal of Clinical Endocrinology & Metabolism, 1997